-
公开(公告)号:EP3349761A1
公开(公告)日:2018-07-25
申请号:EP16847298.3
申请日:2016-09-15
发明人: TURNER, William , ARNOLD, Lee, Daniel , MAAG, Hans , BURES, Mark
IPC分类号: A61K31/554 , C07D281/16 , C07D417/12
CPC分类号: C07D417/12 , A61K45/06 , A61P31/20 , C07D243/38 , C07D267/20 , C07D281/16 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/14 , C07D453/02 , C07D471/04
摘要: The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
-
公开(公告)号:EP3512845A1
公开(公告)日:2019-07-24
申请号:EP17772267.5
申请日:2017-09-14
发明人: TURNER, William , ARNOLD, Lee, Daniel , LI, Leping , BURES, Mark , HAYDAR, Simon , MAAG, Hans , BANNEN, Lynne
IPC分类号: C07D417/12 , C07D513/04 , C07D487/04
-
公开(公告)号:EP3782626A1
公开(公告)日:2021-02-24
申请号:EP20185808.1
申请日:2016-09-15
发明人: TURNER, William , ARNOLD, Lee Daniel , MAAG, Hans , LI, Leping , BURES, Mark , HAYDAR, Simon , FRANCIS, Samson
IPC分类号: A61K31/554 , C07D281/16 , C07D417/12 , C07D417/14 , C07D413/12
摘要: The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
-
公开(公告)号:EP3349580B1
公开(公告)日:2020-08-19
申请号:EP16847295.9
申请日:2016-09-15
发明人: TURNER, William , ARNOLD, Lee, Daniel , MAAG, Hans , LI, Leping , BURES, Mark , HAYDAR, Simon , FRANCIS, Samson
IPC分类号: C07D401/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D243/38 , C07D453/02 , C07D471/04 , C07D267/20 , C07D281/16 , A61K31/551 , A61K31/553 , A61K31/554 , A61P31/20
-
公开(公告)号:EP3349580A1
公开(公告)日:2018-07-25
申请号:EP16847295.9
申请日:2016-09-15
发明人: TURNER, William , ARNOLD, Lee, Daniel , MAAG, Hans , LI, Leping , BURES, Mark , HAYDAR, Simon , FRANCIS, Samson
IPC分类号: A01N57/00
摘要: The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
-
-
-
-